Screener
CONMED CNMD Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $335.56M-0.7% | $343.49M+0.3% | $317.05M-1.3% | $373.2M+7.9% | $337.93M+6.7% | ||
| $146.41M-14.8% | $146.03M-5.2% | $133.6M-6.9% | $154.91M+5.0% | $171.81M+24.8% | ||
| $189.15M+13.9% | $197.46M+4.9% | $183.45M+3.2% | $218.29M+10.1% | $166.12M-7.2% | ||
| 56.4%+7.2pp | 57.5%+2.5pp | 57.9%+2.5pp | 58.5%+1.2pp | 49.2%-7.4pp | ||
| $15.59M+12.1% | $15.5M+9.6% | $16.33M+26.2% | $14.9M+13.1% | $13.9M+2.5% | ||
| $136.42M-2.8% | $145.55M+7.0% | $141.7M-4.8% | $166.76M+25.7% | $140.34M+40.7% | ||
| —— | $19.18M+12.9% | $18.11M+14.1% | $17.47M+0.8% | $16.92M+5.4% | ||
| —— | $31.14M-5.7% | $32.4M-0.8% | $34.35M+22.4% | $31.94M+12.5% | ||
| $152M-1.4% | $161.05M+7.3% | $158.03M-2.3% | $181.66M+24.6% | $154.24M+36.1% | ||
| $37.14M+213% | $36.41M-4.6% | $25.42M+59.3% | $36.62M-30.2% | $11.88M-81.9% | ||
| 11.1%+7.6pp | 10.6%-0.5pp | 8%+3.0pp | 9.8%-5.4pp | 3.5%-17.2pp | ||
| $11.14M+46.4% | $7.88M+0.8% | $7.06M-14.8% | $7.37M-16.8% | $7.61M-17.8% | ||
| $0-100% | $2.83M+776% | $828K+278% | $4K-98.0% | $147K-92.6% | ||
| $26.01M+509% | $31.35M+4.8% | $18.36M+139% | $29.25M-33.0% | $4.27M-92.4% | ||
| $6.21M+339% | $8.28M-2.6% | $4.53M+177% | $12.51M+26.6% | $1.41M-81.1% | ||
| $19.8M+592% | $23.07M+7.7% | $13.83M+129% | $16.74M-50.4% | $2.86M-94.2% | ||
| 5.9%+5.1pp | 6.7%+0.5pp | 4.4%+2.5pp | 4.5%-5.3pp | 0.8%-14.6pp | ||
| $0.66+633% | $0.77+11.6% | $0.45+137% | $0.54-50.0% | $0.09-94.3% | ||
| $49.93M+100% | $47.72M-7.0% | $38.29M+32.5% | $49.79M-23.9% | $24.96M-68.3% | ||
| 14.9%+7.5pp | 13.9%-1.1pp | 12.1%+3.1pp | 13.3%-5.6pp | 7.4%-17.5pp | ||
| $37.14M+213% | $36.41M-4.6% | $25.42M+59.3% | $36.62M-30.2% | $11.88M-81.9% |
FAQ
- What is CONMED's revenue?
- CONMED (CNMD) generated $1.4B in revenue over the trailing twelve months, up 1.6% year over year.
- Is CONMED profitable?
- CONMED reported $73.4M in net income over the trailing twelve months, a 5.4% net margin.
- What are CONMED's profit margins?
- Gross margin is 57.6% and operating margin is 9.9%, with a 5.4% net margin.
- What is CONMED's earnings per share?
- CONMED's diluted EPS over the trailing twelve months is $2.42.
- Where does CONMED's income statement data come from?
- Every line is extracted from CONMED's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
